Abstract. To elucidate the mechanism of action of prostaglandin I 2 (PGI 2 ) and carbaprostacyclin, we studied their effect on DNA synthesis and proliferation in primary cultures of adult rat hepatocytes. Hepatocyte parenchymal cells, maintained in a serum-free, defined medium, synthesized DNA and proliferated in the presence of PGI 2 or carbaprostacyclin in a time-and dose-dependent manner. PGI 2 was less potent than carbaprostacyclin in stimulating hepatocyte mitogenesis. These effects of PGI 2 and carbaprostacyclin were abolished by treatment with a specific IP-receptor antagonist, CAY10441 (10 −9 -10 −7 M). Hepatocyte mitogenesis induced by the IP-receptor agonists was almost completely blocked by specific inhibitors of growth-related signal transducers such as AG1478 (5 × 10 −7 M), LY294002 (10 −7 M), PD98059 (10 −6 M), and rapamycin (10 ng/ ml). In addition, PGI 2 or carbaprostacyclin significantly increased the kinase activity of a (p175 kDa) receptor tyrosine kinase and the phosphorylation of extracellular signalregulated kinase (ERK) 2. Addition of a monoclonal antibody against transforming growth factor (TGF)-α, but not insulin-like growth factor-I, to the culture dose-dependently inhibited the PGI 2 -or carbaprostacyclin-induced hepatocyte mitogenesis. Furthermore, treatment with the IPreceptor agonists significantly increased the secretion of TGF-α to the culture medium. These results indicate that the IP receptor agonist-induced hepatocyte mitogenesis is mediated by autocrine secretion of TGF-α followed by activation of a receptor tyrosine kinase / ERK pathway.